OpenURL Connection Search

Select item for more details and to access through your institution.

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.
Published in:
BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11528-4
By:
- Tsuchihashi, Kenji;
- Ito, Mamoru;
- Arita, Shuji;
- Kusaba, Hitoshi;
- Kusano, Wataru;
- Matsumura, Takashi;
- Kitazono, Takafumi;
- Ueno, Shohei;
- Taguchi, Ryosuke;
- Yoshihiro, Tomoyasu;
- Doi, Yasuhiro;
- Arimizu, Kohei;
- Ohmura, Hirofumi;
- Kajitani, Tatsuhiro;
- Nio, Kenta;
- Nakano, Michitaka;
- Oshima, Kotoe;
- Tamura, Shingo;
- Shirakawa, Tsuyoshi;
- Shimokawa, Hozumi
Publication type:
Article
Predictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma.
Published in:
Molecular & Clinical Oncology, 2017, v. 6, n. 5, p. 669, doi. 10.3892/mco.2017.1205
By:
- HIROFUMI OHMURA;
- KEITA UCHINO;
- TATSUHIRO KAJITANI;
- NAOTAKA SAKAMOTO;
- EISHI BABA
Publication type:
Article
LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer.
Published in:
2017
By:
- Takahashi, Shunji;
- Kobayashi, Takayuki;
- Tomomatsu, Junichi;
- Ito, Yoshinori;
- Oda, Hisanobu;
- Kajitani, Tatsuhiro;
- Kakizume, Tomoyuki;
- Tajima, Takeshi;
- Takeuchi, Hiromi;
- Maacke, Heiko;
- Esaki, Taito
Publication type:
journal article
Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 4, p. 829, doi. 10.1007/s00280-015-2706-y
By:
- Nio, Kenta;
- Arita, Shuji;
- Isobe, Taichi;
- Kusaba, Hitoshi;
- Kohashi, Kenichi;
- Kajitani, Tatsuhiro;
- Tamura, Shingo;
- Hirano, Gen;
- Mitsugi, Kenji;
- Makiyama, Akitaka;
- Esaki, Taito;
- Ariyama, Hiroshi;
- Oda, Yoshinao;
- Akashi, Koichi;
- Baba, Eishi
Publication type:
Article
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer.
Published in:
Gastric Cancer, 2018, v. 21, n. 3, p. 464, doi. 10.1007/s10120-017-0759-9
By:
- Makiyama, Akitaka;
- Arimizu, Kohei;
- Hirano, Gen;
- Makiyama, Chinatsu;
- Matsushita, Yuzo;
- Shirakawa, Tsuyoshi;
- Ohmura, Hirofumi;
- Komoda, Masato;
- Uchino, Keita;
- Inadomi, Kyoko;
- Arita, Shuji;
- Ariyama, Hiroshi;
- Kusaba, Hitoshi;
- Shinohara, Yudai;
- Kuwayama, Miyuki;
- Kajitani, Tatsuhiro;
- Oda, Hisanobu;
- Esaki, Taito;
- Akashi, Koichi;
- Baba, Eishi
Publication type:
Article
Analysis of Response Evaluation Criteria in Solid Tumors reduction ratio of primary chemotherapy in unresectable advanced or recurrent colorectal cancer.
Published in:
Molecular & Clinical Oncology, 2019, v. 11, n. 3, p. 243, doi. 10.3892/mco.2019.1894
By:
- Kawagoe, Shiho;
- Nakano, Masahiro;
- Uchino, Keita;
- Arimizu, Kohei;
- Kajitani, Tatsuhiro;
- Shimokawa, Hozumi;
- Kusumoto, Tetsuya;
- Ikejiri, Koji;
- Baba, Eishi
Publication type:
Article

Found: 6

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.

Predictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma.

LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer.

Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy.

Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer.

Analysis of Response Evaluation Criteria in Solid Tumors reduction ratio of primary chemotherapy in unresectable advanced or recurrent colorectal cancer.